Medizinische Universitätsklinik Bochum

www.medunikkh.de

GMMG-HD 6 Studie A randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintance in patients with newly diagnosed myeloma

Ansprechpartner